Chronic hepatitis B virus (HBV) infection is a serious chronic liver disease caused by the failure of viral clearance following acute HBV infection. Despite the availability of effective prophylactic vaccines, the disease remains a serious global health concern, with estimated over 350 million people worldwide currently living with this condition.
US Drug Hepatitis B Therapeutics Market was valued at $772.8m in 2014. The main driver of the US market over the forecast period will be the launch of novel therapies: most notably, the three adjunct therapies. These agents are aimed to be used alongside marketed oral NAs, and to improve the immunological cure rate, which is measured by the clearance or seroconversion of HBsAg and sustained HBV DNA suppression.
Browse detailed TOC, Tables, figures, Charts and Companies mentioned in Hepatitis B Virus (HBV) Therapeutics - US Drug Forecast and Market Analysis Report at- http://www.marketreportsworld.com/hepatitis-b-virus-hbv-therapeutics-us-drug-forecast-and-market-analysis-to-2024-10163955
Available treatment for chronic hepatitis B focuses on viral suppression, and include oral nucleos(t)ide analogues (NAs) and pegylated interferon (PEG-IFN). The two therapy classes have distinctive strengths and weaknesses. Nevertheless, most patients are using long-term NA treatment, and suffer from issues such as high accumulated treatment cost and low compliance.
Scope of the Hepatitis B Virus (HBV) Therapeutics - US Drug Forecast and Market Analysis Report is as Follows:
- Overview of HBV including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
- Detailed information on the key drugs in the US including product description, safety and efficacy profiles as well as a SWOT analysis.
- Sales forecast for the top drugs in the US from 2014-2024.
- Analysis of the impact of key events as well the drivers and restraints affecting the US HBV market.
Request Sample PDF of Hepatitis B Virus (HBV) Therapeutics - US Drug Forecast and Market Analysis Report at- http://www.marketreportsworld.com/enquiry/request-sample/10163955
Reasons to Buy:
- Understand and capitalize by identifying products that are most likely to ensure a robust return.
- Stay ahead of the competition by understanding the changing competitive landscape for HBV.
- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential.
- Make more informed business decisions from insightful and in-depth analysis of drug performance.
- Obtain sales forecast for drugs from 2014-2024 in US.
Purchase Hepatitis B Virus (HBV) Therapeutics - US Drug Forecast and Market Analysis Report at- http://www.marketreportsworld.com/purchase/10163955
About Market Reports World:
Market Reports World is the credible source for gaining the market research reports that will exponentially accelerate your business. We are among the leading report resellers in the business world committed towards optimizing your business. The reports we provide are based on a research that covers a magnitude of factors such as technological evolution, economic shifts and a detailed study of market segments.
Mr. Ameya Pingaley
Market Reports World
+1-408 520 9750
Email – [email protected]
Website - www.marketreportsworld.com
Market Reports World
Market Reports World is the credible source for gaining the market research reports which will supplement your business with a boost of intelligence. We are among the leading report resellers in the business domain committed towards providing you astute data on market dynamics. A research concocted after assessing current market trends, competition, technological and economic developments is offered to the buyers in the reports we resell. Market Reports World aspire to bestow exhaustive market overview and segmentation which is of a great tactical value for the participants who wish to expedite their growth rate and gain a stronghold in the industry.
P: +1-408 520 9750